1. The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review

   Brahm, C. G., van Linde, M. E., Enting, R. H., Schuur, M., Otten, R. H. J., Heymans, M. W., Verheul, H. M. W. & Walenkamp, A. M. E., 2020, In : Cancers. 12, 3

   Research output: Contribution to journal › Review article › Academic › peer-review

2. Neuroendocrine tumours and their microenvironment

   de Hosson, L. D., Takkenkamp, T. J., Kats-Ugurlu, G., Bouma, G., Bulthuis, M., de Vries, E. G. E., van Faassen, M., Kema, I. P. & Walenkamp, A. M. E., 8-Apr-2020, In : Cancer Immunology Immunotherapy.

   Research output: Contribution to journal › Article › Academic › peer-review

3. High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

   Qiu, S-Q., van Rooijen, J., Nienhuis, H. H., van der Vegt, B., Timmer-Bosscha, H., van Leeuwen-Stok, E., Walenkamp, A. M. E., van Deurzen, C. H. M., de Bock, G. H., de Vries, E. G. E. & Schröder, C. P., 18-Mar-2020, In : Breast cancer research. 22, 1, 10 p., 30.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Towards Optimal Personalized Diet and Vitamin Supplementation in NET Patients; A Feasibility Study

   De Hosson, L. D., Bouma, G., Van Essen, H., Sijtema, B., Huitema, S., Van Faassen, M. J., De Bock, G. H., De Groot, D. J. A., Kema, I. P., De Vries, E. G. E. & Walenkamp, A. M. E., 2017, In : Neuroendocrinology. 105, p. 233 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

5. Defining EGFR amplification status for clinical trial inclusion

   French, P. J., Eoli, M., Sepulveda, J. M., de Heer, I., Kros, J. M., Walenkamp, A., Frenel, J-S., Franceschi, E., Clement, P. M., Weller, M., Ansell, P., Looman, J., Bain, E., Morfouace, M., Gorlia, T. & van den Bent, M., Oct-2019, In : Neuro-Oncology. 21, 10, p. 1263-1272 10 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (95) »